Researchers uncover E. coli's defense mechanismSeptember 29, 2005Iron key to nitric oxide reduction Researchers at the Georgia Institute of Technology and the John Innes Centre in the United Kingdom have uncovered a mechanism with which disease-causing bacteria may thwart the body's natural defense responses. The findings, which could ultimately lead to the development of more effective antibiotics, appear in the September 29, 2005 issue of the journal Nature. "Nitric oxide is produced by the body to fight infections. We discovered a mechanism that allows bacterial cells to detect nitric oxide and turn it into something that's harmless to the cell," said Stephen Spiro, associate professor in the School of Biology at Georgia Tech. Spiro, along with colleagues Benoît D'Autréauz, Nicholas Tucker and Ray Dixon from the John Innes Centre, studied a non-pathogenic strain of Escherichia coli, which is very closely related to Salmonella bacteria. The pathogenic forms of E. coli and Salmonella are usually transmitted to humans through undercooked meat, unwashed vegetables and cross contamination from surfaces on which these foods were prepared. Infections from either of these organisms can cause diarrhea, abdominal cramps and sometimes more serious illnesses that require hospitalization. E.coli doesn't respond well to antibiotics, while Salmonella has developed several drug-resistant strains. Learning how the bacteria handle the body's immune response is the first step in developing more effective medicines. Spiro and colleagues focused their study on the NorR protein and the role it plays in reducing the levels of nitric oxide. In response to nitric oxide, NorR binds to DNA in order to regulate expression of an enzyme that reduces the amount of nitric oxide in the bacteria. Since nitric oxide binds to metals, the researchers suspected that there might be a metal in the protein. "It turns out that the protein NorR contains a single molecule of iron," said Spiro. "Our study found that the nitric oxide binds to the iron, which in turn activates the protein." Once activated, the protein controls expression of the norVW genes. These genes encode an enzyme that removes the nitric oxide, allowing the bacteria to fend off the body's defenses. The discovery of this mechanism is just the first step in what Spiro hopes will be a line of research aimed at disrupting the mechanism by which the bacteria rids itself of the poisonous nitric oxide. "If we can interfere with the mechanism, it could lead to better antibiotics and better treatments," said Spiro. Georgia Institute of Technology |
|||||||||||||||||||||
| Related E. Coli Current Events and E. Coli News Articles Biologists discover bacterial defense mechanism against aggressive oxygen Bacteria possess an ingenious mechanism for preventing oxygen from harming the building blocks of the cell. Study reveals why certain drug combinations backfire Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow. Sweet as can be: how E. coli gets ahead Scientists at the University of York have discovered how certain bacteria such as Escherichia coli have evolved to capture rare sugars from their environment giving them an evolutionary advantage in naturally competitive environments like the human gut. UCSD discovery allows scientists for the first time to experimentally annotate genomes Over the last 20 years, the sequencing of the human genome, along with related organisms, has represented one of the largest scientific endeavors in the history of mankind. There's a speed limit to the pace of evolution, Penn biologists say Researchers at the University of Pennsylvania have developed a theoretical model that informs the understanding of evolution and determines how quickly an organism will evolve using a catalogue of "evolutionary speed limits." Duke develops nano-scale drug delivery for chemotherapy Going smaller could bring better results, especially when it comes to cancer-fighting drugs. Exploring the final frontier: Disease proposed as major barrier to Mars and beyond New research published in the Journal of Leukocyte Biology suggests that prolific virulence and growth of bacteria, coupled with reduced production of antibodies could limit future space travel. Single-stranded DNA-binding protein is dynamic, critical to DNA repair Researchers report that a single-stranded DNA-binding protein (SSB), once thought to be a static player among the many molecules that interact with DNA, actually moves back and forth along single-stranded DNA, gradually allowing other proteins to repair, recombine or replicate the strands. Time in a bottle: Scientists watch evolution unfold A 21-year Michigan State University experiment that distills the essence of evolution in laboratory flasks not only demonstrates natural selection at work, but could lead to biotechnology and medical research advances, researchers said. Parasite growth hormone pushes human cells to liver cancer Scientists have found that the human liver fluke (Opisthorchis viverrini) contributes to the development of bile duct (liver) cancer by secreting granulin, a growth hormone that is known to cause uncontrolled growth of cells. More E. Coli Current Events and E. Coli News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||